Cargando…

Antigen-specific TIL therapy for melanoma: a flexible platform for personalized cancer immunotherapy

Detalles Bibliográficos
Autores principales: Kelderman, Sander, Heemskerk, Bianca, Toebes, Mireille, van Buuren, Marit, van Rooij, Nienke, Bies, Laura, Fanchi, Lorenzo, Germeroth, Lothar, Kvistborg, Pia, Schumacher, Ton
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990297/
http://dx.doi.org/10.1186/2051-1426-1-S1-P19
_version_ 1782312257203470336
author Kelderman, Sander
Heemskerk, Bianca
Toebes, Mireille
van Buuren, Marit
van Rooij, Nienke
Bies, Laura
Fanchi, Lorenzo
Germeroth, Lothar
Kvistborg, Pia
Schumacher, Ton
author_facet Kelderman, Sander
Heemskerk, Bianca
Toebes, Mireille
van Buuren, Marit
van Rooij, Nienke
Bies, Laura
Fanchi, Lorenzo
Germeroth, Lothar
Kvistborg, Pia
Schumacher, Ton
author_sort Kelderman, Sander
collection PubMed
description
format Online
Article
Text
id pubmed-3990297
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39902972014-05-01 Antigen-specific TIL therapy for melanoma: a flexible platform for personalized cancer immunotherapy Kelderman, Sander Heemskerk, Bianca Toebes, Mireille van Buuren, Marit van Rooij, Nienke Bies, Laura Fanchi, Lorenzo Germeroth, Lothar Kvistborg, Pia Schumacher, Ton J Immunother Cancer Poster Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3990297/ http://dx.doi.org/10.1186/2051-1426-1-S1-P19 Text en Copyright © 2013 Kelderman et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Presentation
Kelderman, Sander
Heemskerk, Bianca
Toebes, Mireille
van Buuren, Marit
van Rooij, Nienke
Bies, Laura
Fanchi, Lorenzo
Germeroth, Lothar
Kvistborg, Pia
Schumacher, Ton
Antigen-specific TIL therapy for melanoma: a flexible platform for personalized cancer immunotherapy
title Antigen-specific TIL therapy for melanoma: a flexible platform for personalized cancer immunotherapy
title_full Antigen-specific TIL therapy for melanoma: a flexible platform for personalized cancer immunotherapy
title_fullStr Antigen-specific TIL therapy for melanoma: a flexible platform for personalized cancer immunotherapy
title_full_unstemmed Antigen-specific TIL therapy for melanoma: a flexible platform for personalized cancer immunotherapy
title_short Antigen-specific TIL therapy for melanoma: a flexible platform for personalized cancer immunotherapy
title_sort antigen-specific til therapy for melanoma: a flexible platform for personalized cancer immunotherapy
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990297/
http://dx.doi.org/10.1186/2051-1426-1-S1-P19
work_keys_str_mv AT keldermansander antigenspecifictiltherapyformelanomaaflexibleplatformforpersonalizedcancerimmunotherapy
AT heemskerkbianca antigenspecifictiltherapyformelanomaaflexibleplatformforpersonalizedcancerimmunotherapy
AT toebesmireille antigenspecifictiltherapyformelanomaaflexibleplatformforpersonalizedcancerimmunotherapy
AT vanbuurenmarit antigenspecifictiltherapyformelanomaaflexibleplatformforpersonalizedcancerimmunotherapy
AT vanrooijnienke antigenspecifictiltherapyformelanomaaflexibleplatformforpersonalizedcancerimmunotherapy
AT bieslaura antigenspecifictiltherapyformelanomaaflexibleplatformforpersonalizedcancerimmunotherapy
AT fanchilorenzo antigenspecifictiltherapyformelanomaaflexibleplatformforpersonalizedcancerimmunotherapy
AT germerothlothar antigenspecifictiltherapyformelanomaaflexibleplatformforpersonalizedcancerimmunotherapy
AT kvistborgpia antigenspecifictiltherapyformelanomaaflexibleplatformforpersonalizedcancerimmunotherapy
AT schumacherton antigenspecifictiltherapyformelanomaaflexibleplatformforpersonalizedcancerimmunotherapy